Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?

Published:2014-10-24 Issue:4 Volume:121 Page:517-526
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Paplomata Elisavet¹²,Nahta Rita¹³,O'Regan Ruth M.¹²

Affiliation:

1. Department of Hematology and Medical Oncology; Winship Cancer Institute of Emory University; Atlanta Georgia

2. Department of Hematology and Medical Oncology; Emory University; Georgia Cancer Center for Excellence Grady Memorial Hospital Atlanta Georgia

3. Department of Pharmacology; Emory University; Georgia Cancer Center for Excellence Grady Memorial Hospital Atlanta Georgia

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

5. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer;Frontiers in Oncology;2023-05-01

2. In vivo spectroscopic photoacoustic imaging and laser‐induced nanoparticle vaporization for anti‐HER2 breast cancer;Journal of Biophotonics;2021-07-16

3. Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial;Journal of Clinical Oncology;2020-09-20

4. Discovering and validating cancer genetic dependencies: approaches and pitfalls;Nature Reviews Genetics;2020-06-19

5. Targeted gold nanoshelled hybrid nanocapsules encapsulating doxorubicin for bimodal imaging and near-infrared triggered synergistic therapy of Her2-positve breast cancer;Journal of Biomaterials Applications;2020-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3